Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries.

ABSTRACT:

Importance

Aspirin is an effective and low-cost option for reducing atherosclerotic cardiovascular disease (CVD) events and improving mortality rates among individuals with established CVD. To guide efforts to mitigate the global CVD burden, there is a need to understand current levels of aspirin use for secondary prevention of CVD.

Objective

To report and evaluate aspirin use for secondary prevention of CVD across low-, middle-, and high-income countries.

Design, setting, and participants

Cross-sectional analysis using pooled, individual participant data from nationally representative health surveys conducted between 2013 and 2020 in 51 low-, middle-, and high-income countries. Included surveys contained data on self-reported history of CVD and aspirin use. The sampl

SUBMITTER: Yoo SGK 

PROVIDER: S-EPMC10445202 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature